Association of Oral Anticoagulation Prescription with Clinical Events in Patients with an Asymptomatic Unrepaired Abdominal Aortic Aneurysm
- PMID: 36140213
- PMCID: PMC9495845
- DOI: 10.3390/biomedicines10092112
Association of Oral Anticoagulation Prescription with Clinical Events in Patients with an Asymptomatic Unrepaired Abdominal Aortic Aneurysm
Abstract
Background: Most abdominal aortic aneurysms (AAA) have large volumes of intraluminal thrombus which has been implicated in promoting the risk of major adverse events. The aim of this study was to examine the association of therapeutic anticoagulation with AAA-related events and major adverse cardiovascular events (MACE) in patients with an unrepaired AAA.
Methods: Patients with an asymptomatic unrepaired AAA were recruited from four sites in Australia. The primary outcome was the combined incidence of AAA repair or AAA rupture-related mortality (AAA-related events). The main secondary outcome was MACE (the combined incidence of myocardial infarction, stroke, or cardiovascular death). The associations of anticoagulation with these outcomes were assessed using Cox proportional hazard analyses (reporting hazard ratio, HR, and 95% confidence intervals, CI) to adjust for other risk factors.
Results: A total of 1161 patients were followed for a mean (standard deviation) of 4.9 (4.0) years. Of them, 536 (46.2%) patients had a least one AAA-related event and 319 (27.5%) at least one MACE. In the sample, 98 (8.4%) patients were receiving long-term therapeutic anticoagulation using warfarin (84), apixaban (7), rivaroxaban (6), or dabigatran (1). Prescription of an anticoagulant was associated with a reduced risk of an AAA-related event (adjusted HR 0.61; 95% CI 0.42, 0.90, p = 0.013), but not MACE (HR 1.16; 95% CI 0.78, 1.72, p = 0.476).
Conclusions: These findings suggest that AAA-related events but not MACE may be reduced in patients prescribed an anticoagulant medication. Due to the inherent biases of observational studies, a randomized controlled trial is needed to assess whether anticoagulation reduces the risk of AAA-related events.
Keywords: abdominal aortic aneurysm; rupture and anticoagulation; surgical repair.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Editor's Choice - Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm.Eur J Vasc Endovasc Surg. 2019 Jan;57(1):94-101. doi: 10.1016/j.ejvs.2018.07.035. Epub 2018 Aug 30. Eur J Vasc Endovasc Surg. 2019. PMID: 30174271
-
A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in Patients with Unrepaired Abdominal Aortic Aneurysms.Biomedicines. 2023 Apr 14;11(4):1178. doi: 10.3390/biomedicines11041178. Biomedicines. 2023. PMID: 37189797 Free PMC article. Review.
-
Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm.Trials. 2021 Dec 27;22(1):962. doi: 10.1186/s13063-021-05915-0. Trials. 2021. PMID: 34961561 Free PMC article.
-
Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis.Ont Health Technol Assess Ser. 2002;2(1):1-46. Epub 2002 Mar 1. Ont Health Technol Assess Ser. 2002. PMID: 23074438 Free PMC article.
-
Editor's Choice - Association Between Metformin Prescription and Abdominal Aortic Aneurysm Growth and Clinical Events: a Systematic Review and Meta-Analysis.Eur J Vasc Endovasc Surg. 2021 Nov;62(5):747-756. doi: 10.1016/j.ejvs.2021.06.013. Epub 2021 Sep 21. Eur J Vasc Endovasc Surg. 2021. PMID: 34556425
Cited by
-
Thrombosis in the pathogenesis of abdominal aortic aneurysm.JVS Vasc Sci. 2023 Apr 14;4:100106. doi: 10.1016/j.jvssci.2023.100106. eCollection 2023. JVS Vasc Sci. 2023. PMID: 37564632 Free PMC article. Review.
-
Pathogenesis and management of abdominal aortic aneurysm.Eur Heart J. 2023 Aug 1;44(29):2682-2697. doi: 10.1093/eurheartj/ehad386. Eur Heart J. 2023. PMID: 37387260 Free PMC article. Review.
-
Management of Patients Receiving Anticoagulation Therapy in Dental Practice: A Systematic Review.Healthcare (Basel). 2024 Aug 2;12(15):1537. doi: 10.3390/healthcare12151537. Healthcare (Basel). 2024. PMID: 39120240 Free PMC article. Review.
References
-
- Nastasi D.R., Norman R., Moxon J.V., Quigley F., Velu R., Jenkins J., Golledge J. The Potential Benefits and Costs of an Intensified Approach to Low Density Lipoprotein Cholesterol Lowering in People with Abdominal Aortic Aneurysm. Eur. J. Vasc. Endovasc. Surg. 2021;62:643–650. doi: 10.1016/j.ejvs.2021.06.031. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources